Protiva Biotherapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Protiva Biotherapeutics - overview
Established
2000
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Protiva Biotherapeutics is a US-based biotechnology company that operates as a developer of nucleic acid based pharmaceutical products.
Current Investors
BDC Capital, GrowthWorks Capital, Canadian Medical Discoveries Fund Inc.
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.protivabio.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.